Division of Cardiac Surgery and Corrigan Minehan Heart Center, Massachusetts General Hospital, Boston, MA, USA.
Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.
Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1136-1143. doi: 10.1093/ejcts/ezy443.
Outcomes of cardiac transplantation in patients undergoing reoperative sternotomy are often worse than primary transplants. However, the risks imposed by a prior sternotomy, left ventricular assist device (LVAD) or retransplantation have not been independently analysed.
Using the United Network for Organ Sharing (UNOS) database, a retrospective propensity-matched cohort analysis was performed on 14 730 patients who received a heart transplant between 2005 and 2017. Of 7365 patients who underwent a reoperative sternotomy, 4526 (61%) patients had previous cardiac surgery, 2364 (32%) patients had an LVAD and 475 (6%) patients had a previous transplant. Baseline characteristics were compared, and survival was analysed using a Cox model.
Compared to patients who underwent a primary transplant, patients with a prior sternotomy had a worse long-term survival (P < 0.001). There was no significant difference in survival between patients who had an LVAD and those who had a previous cardiac operation. However, all subgroups had better survival compared to patients who underwent a retransplant (P < 0.05). On the multivariable analysis, prior sternotomy and radiation demonstrated an increased risk of death compared to primary transplants [prior cardiac surgery: hazard ratio (HR) 1.13, 95% confidence interval (CI) 1.05-1.22; P = 0.001; LVAD: HR 1.19, 95% CI 1.08-1.32; P = 0.001; retransplant: HR 1.68, 95% CI 1.42-1.99; P < 0.001; radiation: HR 1.82, 95% CI 1.00-3.30; P = 0.04]. When excluding patients who died in the first year, there were no significant differences in survival between the primary transplant, prior cardiac surgery, LVAD and retransplant groups.
Prior sternotomy is a risk factor for worse survival after cardiac transplantation, mainly due to increased early postoperative mortality. A history of prior transplant confers the greatest risk compared to those who received an LVAD or had prior cardiac surgery.
在接受再次开胸心脏移植的患者中,其术后结局通常比初次移植患者差。然而,既往开胸史、左心室辅助装置(LVAD)或再次移植带来的风险尚未被单独分析。
利用美国器官共享网络(UNOS)数据库,对 2005 年至 2017 年间接受心脏移植的 14730 例患者进行回顾性倾向评分匹配队列分析。在 7365 例行再次开胸的患者中,4526 例(61%)患者有既往心脏手术史,2364 例(32%)患者有 LVAD,475 例(6%)患者有既往移植史。比较了各组的基线特征,并采用 Cox 模型分析了生存率。
与初次移植患者相比,既往开胸患者的长期生存率较差(P<0.001)。有 LVAD 和既往心脏手术史的患者之间的生存率无显著差异。然而,与再次移植患者相比,所有亚组的生存率均较好(P<0.05)。多变量分析显示,与初次移植相比,既往开胸和放疗增加了死亡风险[既往心脏手术:风险比(HR)1.13,95%置信区间(CI)1.05-1.22;P=0.001;LVAD:HR 1.19,95%CI 1.08-1.32;P=0.001;再次移植:HR 1.68,95%CI 1.42-1.99;P<0.001;放疗:HR 1.82,95%CI 1.00-3.30;P=0.04]。当排除移植后 1 年内死亡的患者后,初次移植、既往心脏手术、LVAD 和再次移植组之间的生存率无显著差异。
既往开胸是心脏移植后生存率下降的危险因素,主要原因是术后早期死亡率增加。与接受 LVAD 或既往心脏手术的患者相比,既往移植史的风险最大。